|
A Pilot Study of 5-FC and Genetically-Modified Neural Stem Cells to Treat Gliomas
|
5R21CA137639-02
|
$365,200
|
$91,300
|
PORTNOW, JANA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
ADAM 17 and glioma-tumor progression and treatment
|
5R01CA129446-02
|
$300,875
|
$99,289
|
JIANG, FENG
|
HENRY FORD HEALTH SYSTEM
|
|
Adenovirus-host interactions and in vivo virus targeting
|
5R01CA141439-02
|
$545,162
|
$545,162
|
SHAYAKHMETOV, DMITRY
|
UNIVERSITY OF WASHINGTON
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$1,176,022
|
$470,409
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
|
5R01CA138738-02
|
$393,420
|
$393,420
|
Brentjens, Renier
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
ALL Fusion Proteins: Associated with Multi-protein Complexes and Role in Transcri
|
5R01CA128609-05
|
$313,613
|
$313,613
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
|
An Anti-tumor Therapy Utilizing EP to Deliver IL-15 into B16.F10 Melanoma
|
5F31CA119950-03
|
$32,853
|
$32,853
|
MARRERO, BERNADETTE
|
UNIVERSITY OF SOUTH FLORIDA
|
|
An Integrated Nano-Cell Delivery Platform of Theranostics for Lung Cancers
|
1R01CA152005-01
|
$305,025
|
$305,025
|
Mohapatra, Shyam
|
UNIVERSITY OF SOUTH FLORIDA
|
|
Anti-stathmin Bifunctional Small Hairpin RNA: Preclinical Dev't of High Potency,
|
N43CO100108-000
|
$199,045
|
$199,045
|
Tong, Alex
|
GRADALIS, INC.:1183475
|
|
Antiangiogenic Gene Therapy of Ovarian and Breast Cancers
|
5R01CA114340-04
|
$253,281
|
$253,281
|
RAMAKRISHNAN, SUNDARAM
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Antibody Neutralization of Therapeutic Viruses
|
5R01CA129966-03
|
$508,118
|
$127,030
|
RUSSELL, STEPHEN
|
MAYO CLINIC
|
|
Antibody-mediated Gene Therapy for the Treatment of Cancer
|
5K01CA138559-02
|
$139,465
|
$69,733
|
Daniels, Tracy
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
AP-1 Complexes and Target Gene Regulation
|
5R01CA114381-05
|
$255,536
|
$63,884
|
TAPAROWSKY, ELIZABETH
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
|
Aptamer-siRNA Chimeras Targeting HER2-Positive Breast Cancers
|
5R01CA138503-02
|
$311,250
|
$311,250
|
Giangrande, Paloma
|
UNIVERSITY OF IOWA
|
|
Aspects of MUC13 Mucin in Cancer
|
1R01CA142736-01A1
|
$329,906
|
$164,953
|
Chauhan, Subhash
|
SANFORD RESEARCH/USD
|
|
Basis for Lymphomagenesis in Akt2 Transgenic Mice
|
5R01CA077429-11
|
$452,084
|
$113,021
|
TESTA, JOSEPH
|
FOX CHASE CANCER CENTER
|
|
Biodegradable Polymers For DNA Vaccine Delivery
|
5R01CA129189-03
|
$307,817
|
$153,909
|
WANG, CHUN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Boosting anti-tumor immune responses by modulating genes with nanoparticles
|
5R21CA132026-02
|
$205,073
|
$205,073
|
Conejo-Garcia, Jose
|
DARTMOUTH COLLEGE
|
|
BRAIN TUMOR SPORE GRANT
|
5P50CA097257-09
|
$2,252,870
|
$112,644
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Cancer Cell-Targeted siRNA Delivery by Folate-Conjugated Gold-siRNA-PEG/PEI Nanop
|
1R15CA152822-01
|
$435,000
|
$435,000
|
Huang, Faqing
|
UNIVERSITY OF SOUTHERN MISSISSIPPI
|
|
Cancer Center Training - Experimental Therapy Models
|
5T32CA009363-27
|
$357,320
|
$53,598
|
LAND, HARTMUT
|
UNIVERSITY OF ROCHESTER
|
|
Cancer Education Program
|
5R25CA020449-33
|
$278,989
|
$55,798
|
WOLCHOK, JEDD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-12
|
$534,606
|
$106,921
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Carolina Center of Cancer Nanotechnology Excellence
|
1U54CA151652-01
|
$2,590,876
|
$284,996
|
DESIMONE, JOSEPH
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cell Prep Core
|
ZIC BC 010905
|
$990,728
|
$495,364
|
Wunderlich, John
|
CCR (NCI)
|
|
Cell Production Facility Core
|
ZIC BC 011020
|
$990,727
|
$495,363
|
Dudley, Mark
|
CCR (NCI)
|
|
Cell Therapy of Refractory Leukemia
|
5R01CA113482-05
|
$289,553
|
$95,552
|
CAMPANA, DARIO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cellular co-factors in stable retroviral transduction
|
5R01CA125272-04
|
$235,600
|
$235,600
|
DANIEL, RENE
|
THOMAS JEFFERSON UNIVERSITY
|
|
Cellular Transduction with Replication-Competent Retrovirus Vectors
|
5R01CA121258-04
|
$434,515
|
$434,515
|
KASAHARA, NORIYUKI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Center for Molecular Imaging Research at MGH/HMS
|
5P50CA086355-11
|
$1,923,146
|
$76,926
|
WEISSLEDER, RALPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Center for Translational Cancer Nanomedicine
|
1U54CA151881-01
|
$2,596,014
|
$467,283
|
TORCHILIN, VLADIMIR
|
NORTHEASTERN UNIVERSITY
|
|
Characteristics of Multidrug Resistance in Human Tumors
|
5R01CA040570-23
|
$261,339
|
$65,335
|
BECK, WILLIAM
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Chronic Lymphocytic Leukemia Research Consortium
|
3P01CA081534-11S1
|
$116,714
|
$8,170
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Chronic Lymphocytic Leukemia Research Consortium
|
5P01CA081534-11
|
$4,044,476
|
$283,113
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Clinical and Laboratory Studies of Malignant Lymphomas
|
5P01CA034233-26
|
$1,745,511
|
$349,102
|
LEVY, RONALD
|
STANFORD UNIVERSITY
|
|
Clinical Scholars Biomedical Research Training Program
|
2T32CA009512-24
|
$71,977
|
$14,395
|
KELLY, THOMAS
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Combination Gene Therapy and Th1/Th2 Therapy
|
ZIA BC 011219
|
$272,277
|
$136,139
|
Fowler, Daniel
|
CCR (NCI)
|
|
Combination gene therapy for metastatic colon cancer
|
5R01CA070337-14
|
$287,106
|
$287,106
|
CHEN, SHU-HSIA
|
MOUNT SINAI SCHOOL OF MEDICINE
|
|
COMBINATORIAL-DESIGNED NANO-PLATFORMS TO OVERCOME TUMOR DRUG RESISTANCE
|
1U01CA151452-01
|
$482,687
|
$482,687
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
Conditionally Replicative Adenoviral Vectors for Malignant Glioma
|
5R01CA122930-03
|
$312,391
|
$312,391
|
LESNIAK, MACIEJ
|
UNIVERSITY OF CHICAGO
|
|
Converting an Oncogene to an Apoptotic Factor by Manipulating Signal Sequences
|
5R01CA129528-03
|
$283,656
|
$283,656
|
LIM, CAROL
|
UNIVERSITY OF UTAH
|
|
Coordinating Cell Killing by Communication: Biological Control and Cancer Therapy
|
5R01CA118486-05
|
$208,402
|
$208,402
|
YOU, LINGCHONG
|
DUKE UNIVERSITY
|
|
Cytokine modulated model growth inhibitory mechanisms
|
5R01CA105005-07
|
$269,713
|
$134,857
|
KALVAKOLANU, DHAN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Cytokine Regulation of Normal and Neoplastic Hematopoietic Cell Growth
|
ZIA BC 009264
|
$411,281
|
$8,226
|
Ruscetti, Francis
|
CCR (NCI)
|
|
Designing Lymph Nodes for Cancer Immunotherapy
|
1R01CA148995-01
|
$346,525
|
$346,525
|
MULE, JAMES
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Detection and Analysis of Mouse Retroviruses in Humans
|
ZIA BC 011318
|
$190,044
|
$38,009
|
Maldarelli, Frank
|
CCR (NCI)
|
|
Determining the mechanistic and therapeutic roles of microRNAs in bladder cancer
|
1R01CA138794-01A1
|
$268,920
|
$94,122
|
Liang, Gangning
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Development and evaluation of apoptosis targeted therapies in lung cancer
|
ZIA BC 011049
|
$297,979
|
$297,979
|
Kwong, King
|
CCR (NCI)
|
|
Development of Highly Targeted, Imageable Adenoviral Vectors for Prostate Cancer
|
5R01CA121153-04
|
$311,600
|
$311,600
|
RODRIGUEZ, RONALD
|
JOHNS HOPKINS UNIVERSITY
|
|
Development of Targeted Therapy for ERK Pathway in Breast Cancer
|
5K99CA139006-02
|
$115,239
|
$115,239
|
Bartholomeusz, Chandra
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
Total relevant funding to Gene Therapy for this search: $72,081,945
|